A detailed history of Spectrum Management Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Spectrum Management Group, LLC holds 30,991 shares of ABBV stock, worth $6.02 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares
30,991
Holding current value
$6.02 Million
% of portfolio
0.9%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022

BUY
$134.21 - $153.93 $4.16 Million - $4.77 Million
30,991 New
30,991 $4.16 Million
Q2 2022

Jul 29, 2022

BUY
$137.62 - $174.96 $3.29 Million - $4.18 Million
23,883 Added 347.14%
30,763 $4.71 Million
Q4 2021

Feb 03, 2022

SELL
$107.43 - $135.93 $42,434 - $53,692
-395 Reduced 5.43%
6,880 $932,000
Q3 2021

Nov 03, 2021

BUY
$106.4 - $120.78 $32,239 - $36,596
303 Added 4.35%
7,275 $785,000
Q3 2020

Nov 05, 2020

SELL
$85.91 - $100.83 $4.15 Million - $4.87 Million
-48,250 Reduced 87.37%
6,972 $611,000
Q2 2020

Aug 11, 2020

BUY
$73.37 - $98.18 $3.54 Million - $4.74 Million
48,300 Added 697.78%
55,222 $5.42 Million
Q1 2020

May 08, 2020

BUY
$64.5 - $97.79 $280,252 - $424,897
4,345 Added 168.61%
6,922 $527,000
Q1 2019

Apr 16, 2019

SELL
$77.14 - $90.79 $23,913 - $28,144
-310 Reduced 10.74%
2,577 $208,000
Q3 2018

Oct 30, 2018

SELL
$88.91 - $98.84 $2.54 Million - $2.83 Million
-28,595 Reduced 90.83%
2,887 $273,000
Q2 2018

Jul 30, 2018

BUY
$89.78 - $106.23 $83,495 - $98,793
930 Added 3.04%
31,482 $2.92 Million
Q1 2018

May 07, 2018

BUY
$92.01 - $123.21 $64,407 - $86,247
700 Added 2.34%
30,552 $2.89 Million
Q4 2017

Feb 07, 2018

SELL
$89.56 - $98.21 $249,872 - $274,005
-2,790 Reduced 8.55%
29,852 $2.89 Million
Q3 2017

Nov 07, 2017

BUY
$69.85 - $89.22 $317,258 - $405,237
4,542 Added 16.16%
32,642 $2.9 Million
Q2 2017

Aug 09, 2017

BUY
N/A
28,100
28,100 $2.04 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Spectrum Management Group, LLC Portfolio

Follow Spectrum Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spectrum Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spectrum Management Group, LLC with notifications on news.